Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 300

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Metformin limits osteoarthritis development and progression through activation of AMPK signalling

Open access
Li, Jun, Zhang, Bin, Liu, Wei-Xiao, Lu, Ke, Pan, Haobo, Wang, Tingyu, Oh, Chun-do, Yi, Dan, Huang, Jian, Zhao, Lan, Ning, Guangzhi, Xing, Cong, Xiao, Guozhi, Liu-Bryan, Ru, Feng, Shiqing, Chen, Di · 2020 · Annals of the Rheumatic Diseases

Abstract

OBJECTIVES: In this study, we aim to determine the effect of metformin on osteoarthritis (OA) development and progression. METHODS: Destabilisation of the medial meniscus (DMM) surgery was performed in 10-week-old wild type and AMP-activated protein kinase (AMPK)α1 knockout (KO) mice. Metformin (4 mg/day in drinking water) was given, commencing either 2 weeks before or 2 weeks after DMM surgery. Mice were sacrificed 6 and 12 weeks after DMM surgery. OA phenotype was analysed by micro-computerised tomography (μCT), histology and pain-related behaviour tests. AMPKα1 (catalytic alpha subunit of AMPK) expression was examined by immunohistochemistry and immunofluorescence analyses. The OA phenotype was also determined by μCT and MRI in non-human primates. RESULTS: Metformin upregulated phosphorylated and total AMPK expression in articular cartilage tissue. Mild and more severe cartilage degeneration was observed at 6 and 12 weeks after DMM surgery, evidenced by markedly increased Osteoarthritis Research Society International scores, as well as reduced cartilage areas. The administration of metformin, commencing either before or after DMM surgery, caused significant reduction in cartilage degradation. Prominent synovial hyperplasia and osteophyte formation were observed at both 6 and 12 weeks after DMM surgery; these were significantly inhibited by treatment with metformin either before or after DMM surgery. The protective effects of metformin on OA development were not observed in AMPKα1 KO mice, suggesting that the chondroprotective effect of metformin is mediated by AMPK signalling. In addition, we demonstrated that treatment with metformin could also protect from OA progression in a partial medial meniscectomy animal model in non-human primates. CONCLUSIONS: The present study suggests that metformin, administered shortly after joint injury, can limit OA development and progression in injury-induced OA animal models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2019-216713

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 300

Metadata

Authors
Li, J., Zhang, B., Liu, W.-X., Lu, K., Pan, H., Wang, T., Oh, C.-D., Yi, D., Huang, J., Zhao, L., Ning, G., Xing, C., Xiao, G., Liu-Bryan, R., Feng, S., & Chen, D.
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-05
Volume
79
Issue
5
Pages
635-645
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3011875247
Cited by
300
References
36
FWCI
21.61
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin limits osteoarthritis development and progression through activation of AMPK signalling. https://app.cochat.ai/papers/10.1136/annrheumdis-2019-216713
The paper
Li, J., Zhang, B., Liu, W.-X., Lu, K., Pan, H., Wang, T., Oh, C.-D., Yi, D., Huang, J., Zhao, L., Ning, G., Xing, C., Xiao, G., Liu-Bryan, R., Feng, S., & Chen, D. (2020). Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-216713

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.